Equestre Michele, Marcantonio Cinzia, Marascio Nadia, Centofanti Federica, Martina Antonio, Simeoni Matteo, Suffredini Elisabetta, La Rosa Giuseppina, Bonanno Ferraro Giusy, Mancini Pamela, Veneri Carolina, Matera Giovanni, Quirino Angela, Costantino Angela, Taffon Stefania, Tritarelli Elena, Campanella Carmelo, Pisani Giulio, Nisini Roberto, Spada Enea, Verde Paola, Ciccaglione Anna Rita, Bruni Roberto
Department of Neurosciences, Istituto Superiore di Sanità, 00161 Rome, Italy.
Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Microorganisms. 2023 Nov 5;11(11):2711. doi: 10.3390/microorganisms11112711.
We investigated SARS-CoV-2 variants circulating, from November 2020 to March 2022, among military and civilian personnel at an Air Force airport in Italy in order to classify viral isolates in a potential hotspot for virus spread. Positive samples were subjected to Next-Generation Sequencing (NGS) of the whole viral genome and Sanger sequencing of the spike coding region. Phylogenetic analysis classified viral isolates and traced their evolutionary relationships. Clusters were identified using 70% cut-off. Sequencing methods yielded comparable results in terms of variant classification. In 2020 and 2021, we identified several variants, including B.1.258 (4/67), B.1.177 (9/67), Alpha (B.1.1.7, 9/67), Gamma (P.1.1, 4/67), and Delta (4/67). In 2022, only Omicron and its sub-lineage variants were observed (37/67). SARS-CoV-2 isolates were screened to detect naturally occurring resistance in genomic regions, the target of new therapies, comparing them to the Wuhan Hu-1 reference strain. Interestingly, 2/30 non-Omicron isolates carried the G15S 3CLpro substitution responsible for reduced susceptibility to protease inhibitors. On the other hand, Omicron isolates carried unusual substitutions A1803V, D1809N, and A949T on PLpro, and the D216N on 3CLpro. Finally, the P323L substitution on RdRp coding regions was not associated with the mutational pattern related to polymerase inhibitor resistance. This study highlights the importance of continuous genomic surveillance to monitor SARS-CoV-2 evolution in the general population, as well as in restricted communities.
我们调查了2020年11月至2022年3月期间在意大利一个空军机场的军事和文职人员中传播的新型冠状病毒2(SARS-CoV-2)变体,以便在一个潜在的病毒传播热点对病毒分离株进行分类。对阳性样本进行了整个病毒基因组的下一代测序(NGS)和刺突编码区的桑格测序。系统发育分析对病毒分离株进行了分类并追踪了它们的进化关系。使用70%的截断值来识别聚类。测序方法在变体分类方面产生了可比的结果。在2020年和2021年,我们鉴定出了几种变体,包括B.1.258(4/67)、B.1.177(9/67)、阿尔法(B.1.1.7,9/67)、伽马(P.1.1,4/67)和德尔塔(4/67)。在2022年,仅观察到奥密克戎及其亚系变体(37/67)。对SARS-CoV-2分离株进行了筛选,以检测基因组区域中作为新疗法靶点的天然耐药性,并将它们与武汉Hu-1参考菌株进行比较。有趣的是,2/30的非奥密克戎分离株携带导致对蛋白酶抑制剂敏感性降低的G15S蛋白酶3(3CLpro)替代。另一方面,奥密克戎分离株在木瓜蛋白酶样蛋白酶(PLpro)上携带不寻常的替代A1803V、D1809N和A949T,以及在3CLpro上携带D216N。最后,RNA依赖的RNA聚合酶(RdRp)编码区的P323L替代与聚合酶抑制剂耐药性相关的突变模式无关。这项研究强调了持续进行基因组监测以监测普通人群以及特定社区中SARS-CoV-2进化的重要性。